Global law firm Eversheds has advised the shareholders of over-the-counter (OTC) remedy manufacturer Thornton & Ross in connection with the disposal of the entire issued share capital of the company and its subsidiaries to quoted German generic drug manufacturer, Stada Group.

Founded in 1922, Thornton & Ross Ltd is the largest independent OTC pharmaceutical manufacturer in the UK and exports to over 80 countries worldwide. Its product portfolio encompasses a large number of well-known OTC brands such as Covonia, Hedrin and Setlers, as well as the UK's leading disinfectant Zoflora.T

The Eversheds team was led by Corporate and M&A partners Robin Johnson and Charles Reynard together with Simon Procter, Elizabeth Shepherd, Brett Rowland and Simon Evans. Stada used their in house M&A team.

Charles Reynard commented: “This is a significant deal, which will allow the business to prosper and expand. We wish all involved in the business the very best as the business takes new strides in broader international markets.”

Thornton & Ross Chairman, Jonathan Thornton, said: “Stada Group see the potential in our portfolio of products and have the resource and international reach to develop our business considerably. This acquisition will act as a platform for the growth of their business in the UK and they have reiterated their commitment to the business and its employees in this region.

“We are most grateful to the professional support received from Robin Johnson, Charles Reynard and the Eversheds team, including Simon Procter, who delivered the resource as and when required and pro-actively drove the transaction to a very challenging timetable.”